MILOS study highlights potential of bempedoic acid to advance dyslipidemia treatment: GlobalData EP News Bureau Oct 11, 2024 MILOS study underscores the potential of bempedoic acid to enhance dyslipidemia treatment, particularly for patients with statin…
Cadila Pharma launches Belmore to treat uncontrolled LDL-cholesterol EP News Bureau May 25, 2022 Belmore, the brand name of Bempedoic acid, is a novel drug for the treatment of high LDL-cholesterol
